Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL

AIM: Targeted therapies have substantially improved the survival of patients with metastatic clear cell renal cell cancer. No prognostic or predictive biomarkers are available. Comprehensive genetic profiling offers the opportunity to define prognostic and predictive signatures aiming at a more pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Dieffenbacher, Svenja, Zschäbitz, Stefanie, Hofer, Luisa, Hatiboglu, Gencay, Hou, Weibin, Hohenfellner, Markus, Duensing, Stefan, Sültmann, Holger, Pahernik, Sascha, Grüllich, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2018
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961447/
https://www.ncbi.nlm.nih.gov/pubmed/29796302
http://dx.doi.org/10.4155/fsoa-2017-0150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961447/
https://www.ncbi.nlm.nih.gov/pubmed/29796302
http://dx.doi.org/10.4155/fsoa-2017-0150

Ejemplares similares